By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Intellect Neurosciences, Inc. 

7 West 18th Street
9th Floor
New York  New York  10011  U.S.A.
Phone: 212-448-9300 Fax: 212-448-9600


SEARCH JOBS








Company News
Intellect Neurosciences, Inc. Issues Letter To Shareholders 7/31/2014 10:35:04 AM
Intellect Neurosciences, Inc. Obtains Patent Allowance From The United States Patent And Trademark Office In Relation To Its TOC-1 Monoclonal Antibody Selective For Pre-Fibrillar Tau Aggregates 11/14/2013 1:26:16 PM
Intellect Neurosciences, Inc. Issues Letter to Shareholders 6/20/2013 8:56:40 AM
Intellect Neurosciences, Inc. Engages Evli Corporate Finance to Explore Strategic Alternatives to Maximize Shareholder Value 6/19/2013 9:44:25 AM
Intellect Neurosciences, Inc. Issues Letter to Shareholders 3/29/2013 10:19:53 AM
Intellect Neurosciences, Inc. CEO Daniel Chain Provides Conference Highlights of Alzheimer's Drug Development Summit in Neurotech Insights Magazine 1/2/2013 9:24:04 AM
Intellect Neurosciences, Inc. Issues Letter to Shareholders 10/16/2012 9:36:34 AM
Intellect Neurosciences, Inc. Files Lawsuit Against Pharmaceutical Licensee for Non Payment of $2 Million Milestone 10/15/2012 9:36:41 AM
Intellect Neurosciences, Inc. and iNovacia Enter Research Service Agreement to Evaluate Lead Compounds for CONJUMAB-A Program 10/3/2012 9:36:19 AM
Intellect Neurosciences, Inc. and Medical Research Council Technology Announce Humanization of Next-Generation Monoclonal Antibody to Amyloid Beta With Reduced Potential for Inflammation in the Brain of Alzheimer's Patients 9/19/2012 9:19:58 AM
12345678
//-->